| Not Yet Recruiting | Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NS Locally-Advanced Non-Small Cell Lung Cancer, Radiotherapy | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury | Phase 4 | 2026-04-10 |
| Not Yet Recruiting | Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT. Ventriculoperitoneal Shunt (VPS), Cranioplasty | N/A | 2026-04-01 |
| Recruiting | Anti CD19 Gene Therapy for B-cell Lymphoma B-cell Lymphoma | N/A | 2026-03-20 |
| Not Yet Recruiting | An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Parkinson's Disease | — | 2025-12-15 |
| Not Yet Recruiting | A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combi Esophageal Cancer, Non Small Cell Lung Cancer, Cervical Cancer | Phase 1 | 2025-12-01 |
| Not Yet Recruiting | Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines Cervical Cancer | — | 2025-09-01 |
| Recruiting | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizu Lung Cancer, Esophageal Cancer, Cervical Cancer | Phase 1 | 2025-09-01 |
| Recruiting | The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine Hepatocellular Carcinoma (HCC), Liver Diseases | Phase 4 | 2025-08-30 |
| Recruiting | Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Ad Advanced Solid Tumors | EARLY_Phase 1 | 2025-08-29 |
| Recruiting | Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases Autoimmune Diseases | N/A | 2025-08-25 |
| Not Yet Recruiting | A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Hepatocellular Carcinoma (HCC), Immunotherapy, PD-1 | Phase 2 | 2025-08-20 |
| Not Yet Recruiting | Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia Leukemia | Phase 1 | 2025-08-18 |
| Recruiting | Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia Immune Thrombocytopenia (ITP) | N/A | 2025-08-16 |
| Not Yet Recruiting | QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS) MDS, AML | Phase 1 | 2025-08-15 |
| Not Yet Recruiting | Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Sq Esophageal Carcinoma | Phase 1 | 2025-08-01 |
| Recruiting | Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease Alzheimer Disease (AD) | EARLY_Phase 1 | 2025-07-31 |
| Recruiting | CAR-T Cells Therapy for Patients With Autoimmune Diseases Autoimmune Diseases | N/A | 2025-07-20 |
| Recruiting | Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT Acute Graft Versus Host Disease | Phase 3 | 2025-07-11 |
| Recruiting | Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cel Esophageal Squamous Cell Carcinoma | Phase 2 | 2025-07-01 |
| Recruiting | Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Multiple Myeloma (MM), Plasma Cell Leukemia (PCL), AL Amyloidosis (AL) | EARLY_Phase 1 | 2025-06-23 |
| Not Yet Recruiting | Tumor Immunity and Cancer Recurrence Prediction Model Cancer | — | 2025-06-01 |
| Recruiting | Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photo Artificial Intelligence, Lung Nodule | — | 2025-06-01 |
| Recruiting | Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma Lymphoblastic Leukemia, Relapsed or Refractory Multiple Myeloma (RRMM) | N/A | 2025-04-16 |
| Not Yet Recruiting | Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treat Cancer Treatment-induced Thrombocytopenia (CTIT) | Phase 2 | 2025-03-31 |
| Recruiting | China Liver Cancer Clinical Registry Cohort Database (HEAL) Liver Cancer | — | 2025-01-01 |
| Recruiting | Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithe Ovarian Cancer, Epithelial | — | 2025-01-01 |
| Not Yet Recruiting | The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian Cancer Epithelial Ovarian Cancer, Sentinel Lymph Node Detection | N/A | 2025-01-01 |
| Recruiting | Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metast Prostate Cancer, PET/CT | EARLY_Phase 1 | 2024-12-19 |
| Active Not Recruiting | A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refra Refractory Thrombocytopenia | Phase 1 | 2024-12-04 |
| Recruiting | The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer Prostate Cancer | — | 2024-12-01 |
| Recruiting | Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT Platelet Recovery After Umbilical Cord Blood Transplantation | Phase 2 | 2024-12-01 |
| Not Yet Recruiting | Comparison of Efficacy and Safety Between Ciprofol and Remimazolam During Fiberoptic Bronchoscopy Fiberoptic Bronchoscopy | N/A | 2024-12-01 |
| Recruiting | The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCB Hematopoietic Recovery | Phase 1 | 2024-11-29 |
| Recruiting | Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Po Intrahepatic Cholangiocarcinoma | Phase 2 | 2024-11-16 |
| Recruiting | Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients Thrombocytopenia | Phase 2 | 2024-11-10 |
| Recruiting | Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer Prostate Cancer | — | 2024-10-08 |
| Not Yet Recruiting | Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treat Advanced Ovarian Cancer, AK104(PD-1/CTLA-4 Bispecial Antibody), Chemotherapy | Phase 3 | 2024-10-01 |
| Not Yet Recruiting | Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer Epithelial Ovarian Cancer, Efficacy, Safety | Phase 3 | 2024-10-01 |
| Not Yet Recruiting | iDAP Injection in the Treatment of Parkinson's Disease Parkinson Disease | EARLY_Phase 1 | 2024-10-01 |
| Recruiting | Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy Prostate Cancer | — | 2024-08-30 |
| Recruiting | Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor Chemotherapy-induced Neutropenia | — | 2024-08-15 |
| Not Yet Recruiting | Effect of Nutritional Intervention Based on Prediction Model on Adult Umbilical Cord Blood Transplantation Pat Nutrition Disorders | Phase 2 | 2024-08-01 |
| Recruiting | Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combinat Hepatocellular Carcinoma | Phase 2 | 2024-07-20 |
| Enrolling By Invitation | Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease Alzheimer's Disease Diagnosis | — | 2024-07-11 |
| Recruiting | Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer Small-cell Lung Cancer | Phase 1 / Phase 2 | 2024-07-01 |
| Not Yet Recruiting | Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer | — | 2024-07-01 |
| Not Yet Recruiting | Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Proph Acute Graft Versus Host Disease, Malignant Hematologic Neoplasm | Phase 2 | 2024-07-01 |
| Recruiting | Local Liver Treatment for Multi-organ Colorectal Cancer Metastases Metastatic Colorectal Carcinoma, Multi-organ Metastatic Colorectal Cancer, Metastatic Malignant Neoplasm in the Liver | N/A | 2024-07-01 |
| Enrolling By Invitation | A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis Cirrhosis Liver | Phase 1 | 2024-06-21 |
| Active Not Recruiting | Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer Progression-Free Survival, Overall Survival, Nutrition Aspect of Cancer | — | 2024-06-16 |
| Recruiting | Radiotherapy to All Residual Lesions After Chemoimmunotherapy Extensive-stage Small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-06-01 |
| Not Yet Recruiting | SV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration Alzheimer Disease | — | 2024-06-01 |
| Recruiting | Sulfamethoxazole Prophylaxis Duration After Renal Transplantation Fever, Chest Tightness | N/A | 2024-05-28 |
| Not Yet Recruiting | A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites Gynecologic Cancer | Phase 1 | 2024-05-06 |
| Recruiting | Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT Cytomegalovirus Infection Reactivation | — | 2024-05-01 |
| Recruiting | The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to High Titers of Anti-HLA Antibody (MFI ≥5000) | Phase 2 | 2024-05-01 |
| Recruiting | Cervical Cancer Susceptible Population Classification Cervical Cancer Susceptible Population Classification | — | 2024-05-01 |
| Recruiting | Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metas Prostate Cancer, PET/CT | EARLY_Phase 1 | 2024-04-20 |
| Recruiting | Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metas Prostate Cancer, PET/CT | EARLY_Phase 1 | 2024-04-10 |
| Not Yet Recruiting | The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease Alzheimer's Disease, Mild Cognitive Impairment, Dementia | N/A | 2024-04-01 |
| Recruiting | The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia B Lymphoblastic Leukemia/Lymphoma | EARLY_Phase 1 | 2024-03-15 |
| Recruiting | Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases Acute Graft-versus-host Disease | Phase 3 | 2024-03-15 |
| Recruiting | Differences in Brain Network Mechanisms Between STN and GPi Deep Brain Stimulation in the Treatment of Cranioc Dystonia | N/A | 2024-03-01 |
| Recruiting | Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab Esophageal Squamous Cell Carcinoma | — | 2024-03-01 |
| Active Not Recruiting | Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Acute Graft-versus-host Disease | Phase 3 | 2024-03-01 |
| Recruiting | A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With S Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) | N/A | 2024-02-10 |
| Completed | Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patie Primary Liver Cancer | N/A | 2024-01-04 |
| Recruiting | Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy Esophageal Squamous Cell Carcinoma | N/A | 2024-01-01 |
| Unknown | "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma | Phase 4 | 2023-12-19 |
| Recruiting | An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy Gynecological Malignancies, Menopausal Symptoms, Bone Loss | — | 2023-12-01 |
| Active Not Recruiting | Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer Progression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-up, Overall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up | — | 2023-10-31 |
| Unknown | Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS Myelodysplastic Syndromes | Phase 2 | 2023-10-27 |
| Recruiting | Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer Prostate Cancer | — | 2023-10-08 |
| Unknown | Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML Acute Myelocytic Leukemia | Phase 2 | 2023-10-01 |
| Unknown | Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT Severe Aplastic Anemia | — | 2023-10-01 |
| Recruiting | QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia B-cell Acute Lymphoblastic Leukemia | Phase 1 | 2023-09-27 |
| Recruiting | Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma Esophageal Carcinoma | Phase 1 / Phase 2 | 2023-09-01 |
| Unknown | To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis Cirrhosis, Liver | Phase 1 | 2023-08-09 |
| Unknown | The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prost Prostatic Neoplasms, Frailty, Blood Biological Indicators | — | 2023-07-15 |
| Unknown | Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Met Prostate Cancer, PET/CT | EARLY_Phase 1 | 2023-07-10 |
| Recruiting | Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esoph Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Initial Inoperable | — | 2023-07-01 |
| Recruiting | Minimally Invasive Intracranial Hematoma Aspiration for Spontaneous Intracerebral Hemorrhage Spontaneous Cerebral Hemorrhage | N/A | 2023-07-01 |
| Recruiting | Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition | — | 2023-07-01 |
| Recruiting | Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease Platelet Recovery After Umbilical Cord Blood Transplantation | — | 2023-05-04 |
| Unknown | Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors Hematologic Diseases | Phase 1 | 2023-05-03 |
| Unknown | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinica B-cell Acute Lymphoblastic Leukemia | EARLY_Phase 1 | 2023-02-15 |
| Unknown | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Re Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma | EARLY_Phase 1 | 2023-02-10 |
| Unknown | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Diffuse Large B-cell Lymphoma | EARLY_Phase 1 | 2023-02-10 |
| Unknown | The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients Parkinson Disease | — | 2022-11-30 |
| Unknown | Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model Prostate Cancer | N/A | 2022-11-10 |
| Unknown | Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma HCC | — | 2022-09-30 |
| Recruiting | A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at Hi Hepatocellular Carcinoma | Phase 2 | 2022-07-25 |
| Unknown | A Clinical Study of Portal Vein Embolization and Liver Venous Deprivation Liver Venous Deprivation | N/A | 2022-03-01 |
| Completed | Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2022-03-01 |
| Completed | Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer Safety Issues, Efficacy, Self | N/A | 2022-02-01 |
| Completed | Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal C Toxicity, Drug | Phase 2 | 2021-11-01 |
| Unknown | Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Por HCC, Chemotherapy Effect | Phase 4 | 2021-09-30 |
| Recruiting | Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Toxicity Due to Radiotherapy, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2021-08-01 |
| Completed | Using Teach Back to Improve Postpartum Maternal-infant Health Among Women With Limited Maternal Health Literac Pregnant Women | N/A | 2021-05-17 |
| Completed | A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3 Prostate Cancer | — | 2021-01-01 |
| Unknown | LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants Preterm Infants | Phase 2 | 2020-01-01 |
| Unknown | A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Posit HER2 Positive Breast Carcinoma | — | 2019-04-10 |
| Unknown | Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis Chemotherapy-induced Neutropenia | — | 2018-10-01 |
| Unknown | XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma Gastric Carcinoma | Phase 1 / Phase 2 | 2018-09-01 |
| Unknown | NK Cells Infusion for Advanced Malignancies Immunotherapy | Phase 1 | 2018-07-01 |
| Unknown | Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy. Cervical Cancer | Phase 2 | 2018-06-01 |
| Unknown | Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemother Ovarian Cancer | Phase 2 | 2018-06-01 |
| Unknown | Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer Two Different Treatment Methods | Phase 2 | 2017-10-01 |
| Unknown | Pentoxifylline for the Prevention of PEP Pancreatitis | EARLY_Phase 1 | 2016-12-01 |
| Unknown | Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis Post-ERCP Acute Pancreatitis | Phase 4 | 2016-07-01 |
| Unknown | ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP Post-ERCP Acute Pancreatitis | N/A | 2016-07-01 |
| Unknown | Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma Adenocarcinoma of Lung | Phase 4 | 2016-06-01 |
| Unknown | Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Adenocarcinoma | N/A | 2015-01-01 |
| Completed | Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction Biliary Calculi | Phase 4 | 2014-11-01 |